Research graph
References from Antibody-Directed Effector Cell Therapy of Tumors: Analysis and Optimization Using a Physiologically Based Pharmacokinetic Model. Local targets link to admitted publications; unresolved targets remain external evidence.
Adoptive immunotherapy for cancer
10.1038/scientificamerican0590-62 · 1990 · External reference
Delivery of biological molecules and cells to tumors
2000 · External reference
Targeting of cytotoxic cells against tumors with heterocrosslinked, bispecific antibodies
1988 · External reference
Alternative triggering molecules and single chain bispecific antibodies
10.1089/scd.1.1995.4.377 · 1995 · External reference
Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapy
10.1007/bf02591388 · 1992 · External reference
Bifunctional antibody retargeting in viva-activated T lymphocytes: simplifying clinical application
10.1089/scd.1.1995.4.571 · 1995 · External reference
Anti -cd3xanti-tumor
1995 · External reference
Antitumorxanti -cd3 bifunctional antibodies redirect T-cells activated in viva with staphylococcal enterotoxin b to neutralize pulmonary metastases
1994 · External reference
Specific targeting of in vitro-activated human antitumour effector cells using anti-cd3xanti-c-erbb-2 bispecific antibody
10.1038/icb.1993.11 · 1993 · External reference
Targeted cellular immunotherapy with bifunctional antibodies
1991 · External reference
Changes in leucocyte populations following murine bifunctional antibody infusion in colon cancer patients
10.1111/j.1365-2249.1991.tb08163.x · 1991 · External reference
The mechanism of anti-lyt-2 inhibition of antibody-directed lysis by cytotoxic T lymphocytes
10.4049/jimmunol.139.11.3590 · 1987 · External reference
Treatment of human b cell lymphoma xenografts with a cd3xcdl9 diabody and T cells
10.4049/jimmunol.165.2.888 · 2000 · External reference
Bispecific antibody treatment of murine b cell lymphoma
10.1007/s002620050423 · 1997 · External reference
Effects of radiolabelled murine antibody infusion on TNF-alpha, IL-1 beta, soluble IL-2 receptor in cancer patients
10.1002/jcla.1860080408 · 1994 · External reference
Pharmacokinetic analysis of the perivascular distribution of bifunctional antibodies and haptens: comparison with experimental data
1992 · External reference
Physiologically based kinetic model of effector cell biodistribution in mammals: implications for adoptive immunotherapy
1996 · External reference
10.1038/sj.neo.7900209
10.1038/sj.neo.7900209 · External reference
A bispecific antibody prolongs survival in mice bearing lung metastases of syngeneic mammary adenocarcinoma
10.1093/intimm/7.6.947 · 1995 · External reference
Tumor pretargeting for radioimmunodetection and radioimmunotherapy
1998 · External reference
Physiologically-based pharmacokinetic model for specific and nonspecific monoclonal-antibodies and fragments in normal-tissues and human tumor xenografts in nude-mice
1994 · External reference
The fine structure of tumor blood vessels: I
1985 · External reference
Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood
10.1073/pnas.97.26.14608 · 2000 · External reference
Preferential localization of human adherent lymphokineactivated killer cells in tumor microcirculation
10.1093/jnci/83.6.433 · 1991 · External reference
Physiologically based pharmacokinetic modeling-principles and applications
10.1002/jps.2600721003 · 1983 · External reference
Transport of molecules in the tumor interstitium - a review
1987 · External reference
Determinants of tumor blood-flow - a review
1988 · External reference
Transport of fluid and macromolecules in tumors: 3. Role of binding and metabolism
10.1016/0026-2862(91)90003-t · 1991 · External reference
Unresolved reference
1991 · External reference
